The FDA expanded the approval of pemetrexed for injection to include its use in combination with pembrolizumab and platinum chemotherapy for first-line treatment of metastatic nonsquamous non-small cell lung cancer.
The approval applies to patients with no epidermal growth factor receptor or anaplastic lymphoma kinase (ALK) genomic tumor aberrations.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.